Investment Summary |
|
|---|---|
| Date | 2012-11-05 |
| Target | Lumeon |
| Sector | Information Technology |
| Investor(s) |
Amadeus Capital Partners
EQT Life Sciences Gilde Healthcare |
| Deal Type | Venture |
SEARCH BY
Try For Free 7-Day Free Trial
| Category | Venture Capital Firm |
|---|---|
| Founded | 1997 |
| PE ASSETS | 1.0B USD |
| Size | Large |
| Type | Sector Focused |
Amadeus Capital Partners is an early late-stage investor in high growth European technology companies. Specific areas of interest include AI & machine learning, online consumer services, cybersecurity, digital health and medical technology, digital media, enterprise SaaS, fintech, and insurtech. Amadeus Capital Partners was formed in 1997 and is based in London.
| DEAL STATS | # |
|---|---|
| Overall | 18 of 69 |
| Sector: Information Technology | 6 of 15 |
| Type: | 14 of 60 |
| State: Massachusetts | 1 of 1 |
| Country: United States | 4 of 10 |
| Year: 2012 | 4 of 4 |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2012-01-11 |
Made.com
London, United Kingdom Made.com is an online design brand that offers high-quality furniture. Made.com is bringing consumers a new way to buy furniture, cutting out the middlemen, and hence saving up to 70% off high street prices. Made.com aims to disrupt high-end furniture stores by controlling each element of its supply chain from manufacturing to the e-commerce platform. Made.com was founded in 2010 and is based in London, United Kingdom. |
Buy | - |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2013-04-30 |
ClickTale
Ramat-Gan, Israel ClickTale Ltd. is a provider of customer experience analytics solutions. Clicktale marries cognitive computing, machine learning and psychological research to automatically surface issues and answer questions that keep executives up at night. ClickTale Ltd. was formed in 2006 and is based in Ramat-Gan, Israel. |
Buy | - |
| Category | Growth Capital Firm |
|---|---|
| Founded | 1987 |
| PE ASSETS | 2.0B USD |
| Size | Large |
| Type | Sector Focused |
| DEAL STATS | # |
|---|---|
| Overall | 3 of 47 |
| Sector: Information Technology | 1 of 1 |
| Type: | 3 of 39 |
| State: Massachusetts | 1 of 3 |
| Country: United States | 1 of 11 |
| Year: 2012 | 1 of 1 |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2011-09-13 |
AM-Pharma
Utrecht, Netherlands AM-Pharma is a biopharmaceutical company developing a biotherapeutic for the treatment of Acute Kidney Injury. The company initiated a 290 patient phase 2 study of recombinant human Alkaline Phosphatase in Acute Kidney Injury. AM-Pharma was founded in 2000 and is based in Utrecht, Netherlands. |
Buy | - |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2013-06-26 |
Kiadis Pharma
Amsterdam, Netherlands Kiadis Pharma is a clinical stage biopharmaceutical company pioneering a proprietary cell-based, personalized therapy for patients with blood cancers and related disorders, an area of significant unmet medical need.Kiadis Pharma’s unique and powerful platform technology has led to an initial experimental product, ATIR™, which has already been clinically tested on sixty patients. Kiadis Pharma is based in Amsterdam, Netherlands. |
Buy | - |
| Category | Private Equity Firm |
|---|---|
| Founded | 1982 |
| PE ASSETS | 2.6B EUR |
| Size | Large |
| Type | Sector Focused |
Gilde Healthcare is a specialist private equity and venture investor focused on the healthcare sector. The Firm's buyout group targets majority investments throughout Europe (preference for Germany, the Netherlands, Belgium, Austria or Switzerland) and has a focus on healthcare providers, suppliers and service providers active in the healthcare market. The Firm's venture group looks to invest in early stage medtech, diagnostics, digital health and therapeutics companies throughout North America and Europe. Gilde Healthcare was established in 1982 and is headquartered in Utrecht, Netherlands.
| DEAL STATS | # |
|---|---|
| Overall | 26 of 55 |
| Sector: Information Technology | 2 of 4 |
| Type: | 22 of 31 |
| State: Massachusetts | 3 of 3 |
| Country: United States | 8 of 9 |
| Year: 2012 | 4 of 5 |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2012-10-01 |
Definiens AG
Munich, Germany Definiens AG is a provider of image analysis and data mining solutions for quantitative digital pathology in the life sciences, diagnostic biomarkers and healthcare industries. Definiens software provides detailed readouts from whole tissue slides, cell-based assays and full body scans and allows correlating this information with data derived from other sources. |
Buy | - |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2012-12-20 |
Pharmaline B.V.
Oldenzaal, Netherlands Pharmaline is a specialized manufacturer of unregistered pharmacy products. Pharma Line offers the full package pharmacy preparations that is common in the community pharmacy.This applies both to stock preparations as ad hoc preparations at the patient level in the form of creams, ointments, tablets, capsules, drops, liquids, suspensions, and injectabilia (injections, infusions, cassettes). |
Buy | - |
